Ignite Creation Date:
2024-05-05 @ 12:02 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00226707
Status:
COMPLETED
Last Update Posted:
2008-02-15
First Post:
2005-09-26
Brief Title:
Pimecrolimus Cream 1 in Patients 18 Years of Age and Over With Mild to Moderate Chronic Hand Dermatitis
Sponsor:
Novartis
Organization:
Novartis
Study Overview
Official Title:
A 6-Week Randomized Multicenter Double-Blind Placebo-Controlled Parallel Group Study to Investigate the Efficacy and Safety of Pimecrolimus Cream 1 in Patients With Mild-to-Moderate Chronic Hand Dermatitis Followed by a 6-Week Open-Label Phase to Assess the Safety of Pimecrolimus Cream 1
Status:
COMPLETED
Status Verified Date:
2008-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Topical steroids are standard of care for Chronic Hand Dermatitis but long-term use is associated with adverse effects This study will assess the efficacy and safety of pimecrolimus cream 1 in patients with mild-to-moderate chronic hand dermatitis
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None